Search Within

Center for Hematologic Malignancies

Formats
  1. Journal Article (6192)
  2. Meeting Abstract (6164)
  3. Review (400)
  4. Book Section (216)
  5. Editorial (172)
  6. Research Letter (159)
  7. Guidelines (83)
  8. Conference Paper (70)
  9. Correspondence (61)
  10. Miscellaneous (19)
  11. Book Whole (10)
Groups
  1. Department of Medicine (11088)
  2. Hematologic Malignancies, Division of (10639)
  3. GSK Faculty (5447)
  4. Adult Leukemia (3722)
  5. Sloan Kettering Institute Faculty (3375)
  6. Hematologic Malignancies Research (3005)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (944)
  3. Ross Levine (787)
  4. Andrew Zelenetz (785)
  5. Steven Horwitz (671)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (310)
  2. 2024 (704)
  3. 2023 (877)
  4. 2022 (830)
  5. 2021 (802)
  6. 2020 (874)

More Years

Publications
  1. Blood (3413)
  2. Journal of Clinical Oncology (869)
  3. Biology of Blood and Marrow Transplantation (602)
  4. Clinical Lymphoma, Myeloma and Leukemia (304)
  5. Cancer Research (300)
  6. Haematologica (267)

More Publications

Publishers
  1. American Society of Hematology (3684)
  2. Elsevier Inc. (1668)
  3. Nature Publishing Group (1117)
  4. American Society of Clinical Oncology (918)
  5. American Association for Cancer Research (680)
  6. Wiley Blackwell (437)

More Publishers

Results (13546)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Low proliferation index may be associated with longer time to first therapy in low grade follicular lymphoma
    Meeting Abstract

    Kedmi, M.; Hedvat, C. V.; Maragulia, J.; Zelenetz, A. D.
    Blood (2010)

    Fulltext@MSK | Save
  • Dose response of dysphasia in oropharynx cancer patients
    Meeting Abstract

    Jackson, A.; Caria, N.; Setton, J.; Romanyshyn, J.; McNamara, S. A.; Wolden, S. L.; Lee, N.
    International Journal of Radiation Oncology, Biology, Physics (2010)

    Fulltext@MSK | Save
  • Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-Cell lymphoma (CTCL): Final results of a multicenter dose-finding study
    Meeting Abstract

    Horwitz, S. M.; Kim, Y. H.; Foss, F. M.; Zain, J. M.; Myskowski, P.; Lechowicz, M. J.; Fisher, D. C.; Shustov, A.; Bartlett, N. L.; Delioukina, M. L.; more...
    Blood (2010)

    Fulltext@MSK | Save
  • Pralatrexate efficacy and tolerability in patients with relapsed or refractory cutaneous T-cell lymphoma (CTCL)
    Meeting Abstract

    Horwitz, S.; Duvic, M.; Kim, Y.; Zain, J.; Lechowiz, M.; Koutsoukos, T.; Fruchtman, S.; O'connor, O.
    Haematologica (2010)

    Fulltext@MSK | Save
  • Characteristic proinflammatory serum cytokine profiles in patients with B-Cell chronic lymphocytic leukemia
    Meeting Abstract

    Harding, J. J.; Yeh, R.; Nikhamin, Y.; Frattini, M.; Lamanna, N.; Jurcic, J. G.; Heaney, M.; Brentjens, R.
    Blood (2010)

    Fulltext@MSK | Save
  • Abrogation of donor T cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD From GVL
    Meeting Abstract

    Hanash, A. M.; Kappel, L. W.; Yim, N. L.; Nejat, R. A.; Goldberg, G. L.; Smith, O. M.; Rao, U. K.; Dykstra, L.; Na, I. K.; Holland, A. M.; more...
    Blood (2010)

    Fulltext@MSK | Save
  • Final results of a phase II study of sequential R-CHOP and yttrium-90 ibritumomab tiuxetan (RIT) for elderly high risk patients with untreated diffuse large B-cell lymphoma (DLBCL)
    Meeting Abstract

    Hamlin, P. A. Jr; Rodriguez, M. A.; Noy, A.; Portlock, C. S.; Straus, D.; McLaughlin, P.; Pro, B.; Fayad, L.; Hagemeister, F.; Wegner, B.; more...
    Blood (2010)

    Fulltext@MSK | Save
  • Genetic engineering of donor T cells for BMT immunotherapy: Expression of TRAIL and PLZF selectively enhances GVT and abrogates GVHD
    Meeting Abstract

    Ghosh, A.; Holland, A. M.; Dogan, Y.; Yim, N.; Rao, U. K.; Young, L. F.; Smith, O. M.; Jenq, R.; Na, I. K.; Tsai, J.; more...
    Blood (2010)

    Fulltext@MSK | Save
  • High mitochondrial membrane potential identifies patients with myeloproliferative neoplasms with a more aggressive natural history
    Meeting Abstract

    Gardner, J. R.; Abdel-Wahab, O.; Frattini, M.; Jurcic, J. G.; Knapp, K.; Rosenblat, T. L.; Soff, G. A.; Levine, R.; Heaney, M.
    Blood (2010)

    Fulltext@MSK | Save
  • Outcomes following salvage autologous stem cell transplant for multiple myeloma
    Meeting Abstract

    Fein, D. E.; Hassoun, H.; Comenzo, R. L.; Lesokhin, A.; Lendvai, N.; Chung, D.; Cohen, A.; Rosenzweig, M. A.; Chimento, D.; Jia, X.; more...
    Blood (2010)

    Fulltext@MSK | Save